Cross-linking is not, per se, a refractive procedure, as improvements in acuity and refractive error are modest in the best scenarios. A logical question might therefore arise: if CXL is not a refractive procedure, why does it occupy so many pages of a journal devoted solely to refractive surgery? The reasons are many currently, as refractive surgeons are frequently the individuals with whom patients with ectatic corneal disease initially interact, and these reasons may grow as refractive surgical procedures and CXL become increasingly linked together in our treatment armamentarium. The newer applications of CXL are simultaneously of great interest to our profession and also remain to be thoroughly evaluated; hence, the number of articles in this issue of JRS.
展开▼
